CBIZ Investment Advisory Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,991
Closed -$190K – 456
2025
Q4
$190K Buy
1,991
+70
+4% +$6.86K 0.01% 59
2025
Q3
$188K Sell
1,921
-986
-34% -$102K 0.01% 52
2025
Q2
$312K Sell
2,907
-169
-5% -$17.1K 0.01% 41
2025
Q1
$310K Sell
3,076
-4
-0.1% -$403 0.02% 41
2024
Q4
$275K Buy
3,080
+900
+41% +$79.2K 0.01% 43
2024
Q3
$183K Buy
2,180
+450
+26% +$35.5K 0.01% 52
2024
Q2
$133K Hold
1,730
– – 0.01% 58
2024
Q1
$118K Buy
+1,730
New +$111K 0.01% 64

Other funds holding BSX

CBIZ Investment Advisory Services's BSX Position: Q1 2026 in Review

CBIZ Investment Advisory Services sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 1,991 shares — an estimated $190K sold.

CBIZ Investment Advisory Services first reported a position in BSX in Q1 2024 and held it in 8 quarters. The position peaked at $312K in Q2 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • CBIZ Investment Advisory Services reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • CBIZ Investment Advisory Services sold 1,991 Boston Scientific shares in Q1 2026, an estimated $190K.
  • CBIZ Investment Advisory Services first reported a position in Boston Scientific in Q1 2024 and held it in 8 quarters.
  • CBIZ Investment Advisory Services's Boston Scientific position peaked at $312K in Q2 2025.
  • 1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.